Intrinsic and Acquired Resistance in Cancer: Getting Smarter About Combinations and Sequencing

Moderator:

  • Neal Rosen, MD, PhD, Director, Center for Mechanism-Based Therapeutics, Memorial Sloan-Kettering Cancer Center

Panelists:

  • Jeffrey A. Engelman, MD, PhD, Director of Thoracic Oncology and Director of Molecular Therapeutics, Massachusetts General Hospital Cancer Center
  • Greg Plowman, MD, PhD, VP, Oncology Research Eli Lilly and Company
  • David Solit, MD, Director, Developmental Therapeutics, Memorial Sloan-Kettering Cancer Center